Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)

China flag China · Delayed Price · Currency is CNY
19.50
-0.39 (-1.96%)
Apr 30, 2026, 3:00 PM CST
Market Cap3.53B +5.4%
Revenue (ttm)124.82M -30.1%
Net Income-34.30M
EPS-0.19
Shares Out177.52M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,278,153
Average Volume3,684,182
Open19.75
Previous Close19.89
Day's Range19.40 - 19.87
52-Week Range16.05 - 29.49
Beta0.56
RSI41.79
Earnings DateApr 24, 2026

About Shanghai ZJ Bio-Tech

Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. It offers nucleic acid and real-time PCR kits, as well as consumables. The company was founded in 2005 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2005
Employees 275
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688317
Full Company Profile

Financial Performance

In 2025, Shanghai ZJ Bio-Tech's revenue was 124.82 million, a decrease of -30.13% compared to the previous year's 178.65 million. Losses were -34.30 million, -73.09% less than in 2024.

Financial Statements